Real world outcomes in patients with recurrent, advanced, or metastatic endometrial cancer treated with lenvatinib plus pembrolizumab

Cover Page

Cite item

Full Text

About the authors

A. Pawsey

University College London Hospitals NHS Foundation Trust

Author for correspondence.
Email: alexpawsey@doctors.org.uk

Alexander Pawsey

United Kingdom

P. Mahalingam

Imperial College Healthcare NHS Trust

United Kingdom

N. Senthivel

Royal Surrey County Hospital NHS Foundation Trust, St. Luke’s Cancer Centre

United Kingdom

A. Ramessur

Guy’s and St. Thomas’ Hospitals NHS Trust

United Kingdom

E. Turnbull

Royal Cornwall Hospitals NHS Trust

United Kingdom

S. Usman

Colchester Hospital University NHS Foundation Trust

United Kingdom

R. Browne

University College London Hospitals NHS Foundation Trust

United Kingdom

A. Patel

University College London Hospitals NHS Foundation Trust

United Kingdom

A. Stewart

Royal Surrey County Hospital NHS Foundation Trust

United Kingdom

L. Tookman

Imperial College Healthcare NHS Trust London

United Kingdom

N. Counsell

University College London, Cancer Trials Centre London

United Kingdom

R. Miller

University College London Hospitals NHS Foundation Trust

United Kingdom

S. Nicum

University College London Hospitals NHS Foundation Trust

United Kingdom

G. Eminowicz

University College London Hospitals NHS Foundation Trust

United Kingdom

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36991 от  21.07.2009.